Maleimide constrained BAD BH3 domain peptides as BCL-xL Inhibitors: A versatile approach to rapidly identify sites compatible with peptide constraining-Reference-Cited by-同舟云学术

Maleimide constrained BAD BH3 domain peptides as BCL-xL Inhibitors: A versatile approach to rapidly identify sites compatible with peptide constraining

Published:2023-05 Issue: Volume:87 Page:129260
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Zhang Peiyu,Walko Martin,Wilson Andrew J

Funder

University of Leeds

China Scholarship Council

Engineering and Physical Sciences Research Council

Biotechnology and Biological Sciences Research Council

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference62 articles.

1. Strategies for targeting protein-protein interactions with synthetic agents;Yin;Angew. Chem. Int. Ed.,2005

2. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge;Scott;Nat. Rev. Drug Discov.,2016

3. Inhibition of α -helix-mediated protein-protein interactions using designed molecules;Azzarito;Nat. Chem.,2013

4. Peptide therapeutics: current status and future directions;Fosgerau;Drug Discov. Today,2015

5. Structure-based design of inhibitors of protein-protein interactions: mimicking peptide binding epitopes;Pelay-Gimeno;Angew. Chem. Int. Ed.,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Aurora‐A/N‐Myc Protein–Protein Interaction Using Peptidomimetics: Understanding the Role of Peptide Cyclization**;ChemBioChem;2023-11-27